Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.
about
Infectious Complications after Umbilical Cord-Blood Transplantation from Unrelated DonorsDonor cell leukemia in umbilical cord blood transplant patients: a case study and literature review highlighting the importance of molecular engraftment analysisMonitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantationSuccessful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes.Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.Umbilical-cord blood transplantation for the treatment of cancer.Treatment of Epstein-Barr virus--associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: a case report and literature review.Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development.EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning.Infectious complications following unrelated cord blood transplantation.Umbilical cord blood transplantation in adult myeloid leukemia.Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood.Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation.Secondary cancers following allogeneic haematopoietic cell transplantation in adults.Endobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation.Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation.Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasm.Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen.
P2860
Q28066500-373873AF-EAA6-4DA9-9E97-73148B679D73Q33947117-7D917B22-89C8-4415-9217-1FE012B26877Q33962254-9824FCE5-A794-4B3F-9015-F44DCD2C5F67Q34450754-4577C06F-FA43-46FA-998E-6C47E0F7ACDBQ34622755-FFBB1B54-EB7A-40AC-8DC4-E4A7B8C21BCCQ35166819-4F819252-22E3-4CE8-B480-53345B616C10Q36307574-C3AF9A5A-F6E1-47E6-92E6-57F1EB2ECBA4Q36389306-D77C42BA-A110-4453-8F61-36E18674963DQ36746437-10212C33-1067-4763-8249-5F80B9AFB076Q36800530-F65B3630-11E6-4443-A17F-54B43D977FB2Q37075874-A5E8B212-1D82-4BD8-9755-5E9081D2F7FEQ37435417-E477A9BA-484A-471B-BA13-9A748FB8820AQ37793222-FFCDEC62-AC18-47F7-8B48-A26E3645DA65Q37880254-18D63CF6-BF59-4FE2-B0FE-065DD7536410Q41908744-264A78B9-C27D-4C7E-844C-F8DF812D73B6Q42154867-C6F86E53-39F0-479B-8241-86C1605F2728Q46112355-148EBEF2-A832-43D4-8277-8B4E0F007D04Q53251807-12A5B3DA-E459-4585-B84D-4234BCD31044
P2860
Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Low incidence of Epstein-Barr ...... d blood transplant recipients.
@en
Low incidence of Epstein-Barr ...... d blood transplant recipients.
@nl
type
label
Low incidence of Epstein-Barr ...... d blood transplant recipients.
@en
Low incidence of Epstein-Barr ...... d blood transplant recipients.
@nl
prefLabel
Low incidence of Epstein-Barr ...... d blood transplant recipients.
@en
Low incidence of Epstein-Barr ...... d blood transplant recipients.
@nl
P2093
P1476
Low incidence of Epstein-Barr ...... d blood transplant recipients.
@en
P2093
Kurtzberg J
Weisdorf DJ
P304
P356
10.1053/BBMT.2001.V7.PM11529490
P577
2001-01-01T00:00:00Z